FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: A prospective evaluation Academic Article uri icon

Overview

MeSH Major

  • Chemoradiotherapy
  • Fluorodeoxyglucose F18
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Rectal Neoplasms

abstract

  • Assessment of rectal cancer response to neoadjuvant chemoradiotherapy by FDG-PET provides no prognostic information. Therefore, serial FDG-PET before and after neoadjuvant chemoradiotherapy should not be performed for this purpose.

publication date

  • April 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/DCR.0b013e318244a666

PubMed ID

  • 22426260

Additional Document Info

start page

  • 378

end page

  • 86

volume

  • 55

number

  • 4